l9n/ New Jersey

2020–2021 Session

Assembly Bill 277

Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*

Became P.L.2021, c.285, on November 8, 2021.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the General Assembly

2 co-sponsors

Roy Freiman, Joann Downey

In the Senate

Its course

January 14, 2020 to November 8, 2021, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action8 actions on 7 days

In the General AssemblyJan 14 to Jul 30198 days

HealthJan 14 to Mar 551 days

In the SenateJul 30 to Jun 3308 days

With the GovernorJun 3 to Nov 8158 days

Votes

Yeas to nays, as the Legislature recorded them. Committee votes are set in.

Amendments

Each amendment offered, and what became of it.

  • General Assembly committee amendmentAdopted

    Adopted Mar 5

Text

Each version as the Legislature printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislature published it is below.

In the General Assembly Jan 14 – Jul 30

  1. Introduced in the General Assembly and sent to Health
  2. Health recommended it as amended
  3. Read a second time
  4. Passed the General Assembly, 74 to 0

In the Senate Aug 3 – Jun 3, 2021

  1. Arrived in the Senate
  2. Sent to Health, Human Services and Senior Citizens
  3. Health, Human Services and Senior Citizens recommended it
  4. Read a second time
  5. Passed the Senate, 38 to 0, and so both houses

To the Governor Nov 8, 2021

  1. Signed by the Governor
  2. Became P.L.2021, c.285
All 8 actions, as published